VYNE Therapeutics Inc. logo

VYNE Therapeutics Inc.

1566044

VYNE Therapeutics is dedicated to improving patients' lives by developing proprietary, innovative therapies for immuno-inflammatory conditions. They work to solve difficult therapeutic challenges by questioning traditional assumptions to find better solutions. Their pipeline includes InhiBET™ BET Inhibitor Platform, VYN201, and VYN202, advancing new medicines through clinical development.

89
Altamente Confiable
Puntuación de Confianza

Registro Oficial

Nombre Legal
VYNE Therapeutics Inc.
Número de organización
1566044
Estado de la Empresa
Active

Análisis de Calidad IA

Industria
Biopharmaceutical
SSL/HTTPS
Seguro
Correo profesional
Correo de contacto
ir@vynetx.com

Desglose de Puntuación de Confianza

Registro Verificado35/35
Puntuación de Calidad54/60
Sentimiento de Noticias0/5

Enlaces Rápidos

Última actualización: 12/30/2025

🌟 Empresas similares de confianza

BRISTOL MYERS SQUIBB CO

BRISTOL MYERS SQUIBB CO logo
75/100 · Confiable

Bristol Myers Squibb (BMS) is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines. Their key products and services include treatments for cancer, cardiovascular disease, immunology, and other serious diseases. BMS is positioned as a leading company in the pharmaceutical industry, with a commitment to research and development to improve patient outcomes.

Estados Unidos
Ver perfil

AVADEL PHARMACEUTICALS PLC

AVADEL PHARMACEUTICALS PLC logo
86/100 · Altamente Confiable

Avadel is a biopharmaceutical company focused on transforming medicines to transform lives. They develop innovative solutions for medications that address the challenges patients face with current treatment options. Avadel is disrupting treatment paradigms where it's needed most, starting with narcolepsy.

Estados Unidos
Ver perfil

Grifols SA

Grifols SA logo
86/100 · Altamente Confiable

Since 1909, Grifols has worked to improve the health and well-being of people worldwide. They develop, produce, and market innovative medicines, solutions, and services in over 110 countries. Grifols is a global leader in biopharmaceuticals and diagnostics, with a focus on plasma-derived therapies. They are committed to innovation and sustainability.

Estados Unidos
Ver perfil